A Mutant of Human Papillomavirus Type 16 E6 Deficient in Binding α-Helix Partners Displays Reduced Oncogenic Potential In Vivo

ABSTRACT Human papillomaviruses (HPVs) are small DNA tumor viruses that are the causative agent of warts and are associated with many anogenital cancers. The viral gene encoding the E6 protein has been found to be involved in HPV oncogenesis. E6 is known to inactivate the cellular tumor suppressor, p53. In addition, E6 has been shown to bind to a variety of other cellular proteins. The focus of this study was to determine what role the interactions of E6 with a subset of cellular proteins which contain a common α-helical domain in their E6 binding region (α-helix partners) play in E6-mediated phenotypes. We generated transgenic mice expressing a mutant of E6, E6I128T, which is defective for binding at least a subset of the α-helix partners, including E6AP, the ubiquitin ligase that mediates E6-dependent degradation of the p53 protein, to determine whether binding of α-helix partners plays a role in E6-mediated activities in vivo. Unlike mice expressing the wild-type E6 (strain K14E6WT), the mice expressing E6I128T lacked the ability to alter the radiation-induced block to DNA synthesis and promote the formation of benign skin tumors in conjunction with chemical carcinogens. Additionally, they displayed reduced levels of skin hyperplasia, spontaneous skin tumors, and tumor progression activity compared to those of the K14E6WT mice. From these results, we conclude that a domain in E6 that mediates α-helix partner binding is critical for E6-induced phenotypes in transgenic mice.

[1]  P. Howley,et al.  Identification of HHR23A as a Substrate for E6-associated Protein-mediated Ubiquitination* , 1999, The Journal of Biological Chemistry.

[2]  L. Donehower,et al.  Reduction of p53 gene dosage does not increase initiation or promotion but enhances malignant progression of chemically induced skin tumors , 1993, Cell.

[3]  H. Pitot,et al.  The Human Papillomavirus Type 16 E6 Gene Alone Is Sufficient To Induce Carcinomas in Transgenic Animals , 1999, Journal of Virology.

[4]  L. Banks,et al.  Human papillomavirus type 16 E6 gene cooperates with EJ-ras to immortalize primary mouse cells. , 1993, Oncogene.

[5]  Miranda Thomas,et al.  Interactions of the PDZ-protein MAGI-1 with adenovirus E4-ORF1 and high-risk papillomavirus E6 oncoproteins , 2000, Oncogene.

[6]  R. Salgia,et al.  The Bovine Papillomavirus E6 Protein Binds to the LD Motif Repeats of Paxillin and Blocks Its Interaction with Vinculin and the Focal Adhesion Kinase* , 1997, The Journal of Biological Chemistry.

[7]  Ajay Mahaputra Kumar,et al.  PKN Binds and Phosphorylates Human Papillomavirus E6 Oncoprotein* , 2000, The Journal of Biological Chemistry.

[8]  B. Dasgupta,et al.  Competitive binding to a charged leucine motif represses transformation by a papillomavirus E6 oncoprotein. , 2000, Virology.

[9]  D. Lowy,et al.  HPV16 E6 and E7 proteins cooperate to immortalize human foreskin keratinocytes. , 1989, The EMBO journal.

[10]  J. Shay,et al.  E6 of human papillomavirus type 16 can overcome the M1 stage of immortalization in human mammary epithelial cells but not in human fibroblasts. , 1993, Oncogene.

[11]  J. Miller,et al.  Human papillomavirus types 16 E6 and E7 contribute differently to carcinogenesis. , 2000, Virology.

[12]  J. Huibregtse,et al.  Human Scribble (Vartul) Is Targeted for Ubiquitin-Mediated Degradation by the High-Risk Papillomavirus E6 Proteins and the E6AP Ubiquitin-Protein Ligase , 2000, Molecular and Cellular Biology.

[13]  E. Androphy,et al.  Solution structure determination and mutational analysis of the papillomavirus E6 interacting peptide of E6AP. , 2001, Biochemistry.

[14]  D. Wazer,et al.  The E6 Oncoproteins of High-Risk Papillomaviruses Bind to a Novel Putative GAP Protein, E6TP1, and Target It for Degradation , 1999, Molecular and Cellular Biology.

[15]  R. Maronpot,et al.  Spontaneous Lesions in Aging FVB/N Mice , 1996, Toxicologic pathology.

[16]  D. Patel,et al.  The E6 protein of human papillomavirus type 16 binds to and inhibits co‐activation by CBP and p300 , 1999, The EMBO journal.

[17]  T. Iftner,et al.  A comparative analysis of the interactions of the E6 proteins from cutaneous and genital papillomaviruses with p53 and E6AP in correlation to their transforming potential. , 1997, Virology.

[18]  M. O’Connor,et al.  The Human Papillomavirus Type 16 E6 Oncoprotein Can Down-Regulate p53 Activity by Targeting the Transcriptional Coactivator CBP/p300 , 1999, Journal of Virology.

[19]  P. Howley,et al.  The bovine papillomavirus E6 oncoprotein interacts with paxillin and disrupts the actin cytoskeleton. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[20]  J. Schiller,et al.  Human papillomavirus type 16 E6 increases the degradation rate of p53 in human keratinocytes , 1992, Journal of virology.

[21]  C. Turner,et al.  Association of Bovine Papillomavirus Type 1 E6 oncoprotein with the focal adhesion protein paxillin through a conserved protein interaction motif , 1998, Oncogene.

[22]  T. Kanda,et al.  Human papillomavirus oncoprotein E6 binds to the C-terminal region of human minichromosome maintenance 7 protein. , 1998, Biochemical and biophysical research communications.

[23]  P. Lambert,et al.  Human papillomavirus type 16 E6 and E7 oncogenes abrogate radiation-induced DNA damage responses in vivo through p53-dependent and p53-independent pathways. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[24]  Miranda Thomas,et al.  Inhibition of Bak-induced apoptosis by HPV-18 E6 , 1998, Oncogene.

[25]  M. Scheffner,et al.  A cellular protein mediates association of p53 with the E6 oncoprotein of human papillomavirus types 16 or 18. , 1991, The EMBO journal.

[26]  R. Mcglennen,et al.  The E6 gene of human papillomavirus type 16 is sufficient for transformation of baby rat kidney cells in cotransfection with activated Ha-ras. , 1994, Virology.

[27]  E. Androphy,et al.  Multiple Functions of Human Papillomavirus Type 16 E6 Contribute to the Immortalization of Mammary Epithelial Cells , 1999, Journal of Virology.

[28]  T. Kiyono,et al.  Both Rb/p16INK4a inactivation and telomerase activity are required to immortalize human epithelial cells , 1998, Nature.

[29]  M. Scheffner,et al.  E6-AP directs the HPV E6-dependent inactivation of p53 and is representative of a family of structurally and functionally related proteins. , 1994, Cold Spring Harbor symposia on quantitative biology.

[30]  R. Schlegel,et al.  The E6 and E7 genes of the human papillomavirus type 16 together are necessary and sufficient for transformation of primary human keratinocytes , 1989, Journal of virology.

[31]  M. Vidal,et al.  Human papillomavirus 16 E6 oncoprotein binds to interferon regulatory factor-3 and inhibits its transcriptional activity. , 1998, Genes & development.

[32]  L. Banks,et al.  Multi-PDZ Domain Protein MUPP1 Is a Cellular Target for both Adenovirus E4-ORF1 and High-Risk Papillomavirus Type 18 E6 Oncoproteins , 2000, Journal of Virology.

[33]  P. May,et al.  Twenty years of p53 research: structural and functional aspects of the p53 protein , 1999, Oncogene.

[34]  M. Sheng,et al.  Regulation of Dendritic Spine Morphology by SPAR, a PSD-95-Associated RapGAP , 2001, Neuron.

[35]  A. Levine,et al.  Association of human papillomavirus types 16 and 18 E6 proteins with p53. , 1990, Science.

[36]  P. Howley,et al.  Human Papillomavirus Type 16 E6 Induces Self-Ubiquitination of the E6AP Ubiquitin-Protein Ligase , 2000, Journal of Virology.

[37]  P. Howley,et al.  The Role of E6AP in the Regulation of p53 Protein Levels in Human Papillomavirus (HPV)-positive and HPV-negative Cells* , 1998, The Journal of Biological Chemistry.

[38]  S. S. Lee,et al.  Binding of human virus oncoproteins to hDlg/SAP97, a mammalian homolog of the Drosophila discs large tumor suppressor protein. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[39]  S. Silverstein,et al.  Gps2, a Protein Partner for Human Papillomavirus E6 Proteins , 2001, Journal of Virology.

[40]  D. Wazer,et al.  Human Papillomavirus Type 16 E6-Induced Degradation of E6TP1 Correlates with Its Ability To Immortalize Human Mammary Epithelial Cells , 2001, Journal of Virology.

[41]  E. Androphy,et al.  Interaction of papillomavirus E6 oncoproteins with a putative calcium-binding protein. , 1995, Science.

[42]  M. Scheffner,et al.  The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53 , 1993, Cell.

[43]  R. Elston,et al.  The identification of a conserved binding motif within human papillomavirus type 16 E6 binding peptides, E6AP and E6BP. , 1998, The Journal of general virology.

[44]  Santhosh K. P. Kumar,et al.  Regulation of the Src family tyrosine kinase Blk through E6AP-mediated ubiquitination. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[45]  E. Androphy,et al.  Identification of an α Helical Motif Sufficient for Association with Papillomavirus E6* , 1998, The Journal of Biological Chemistry.

[46]  M Fujita,et al.  Binding of high-risk human papillomavirus E6 oncoproteins to the human homologue of the Drosophila discs large tumor suppressor protein. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[47]  L. Banks,et al.  E3-Ubiquitin Ligase/E6-AP Links Multicopy Maintenance Protein 7 to the Ubiquitination Pathway by a Novel Motif, the L2G Box* , 1998, The Journal of Biological Chemistry.